Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-04

Clinical Trial Update: Aspirin Prophylaxis in Sickle Cell Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated aspirin prophylaxis in patients with sickle cell disease; results were posted after completion in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Rochester | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-01-04